banakay
Networker
Mohs LCD guidelines have been updated with new verbiage to specifically require in part:
MLN Matters®Number: SE1318
http://www.cms.gov/Outreach-and-Edu...k-MLN/MLNMattersArticles/Downloads/SE1318.pdf
"...... You must describe the histology of the specimens taken in the first stage. That description should include depth of invasion, pathological pattern, cell morphology, and, if present, perineural invasion or presence of scar tissue. For subsequent stages, you may note that the pattern and morphology of the tumor (if still seen) is as described for the first stage; or, if differences are found, note the changes. There is no need to repeat the detailed description documented for the first stage, presuming that the description would fit the tumor found on subsequent stages."
To access the revised LCDs, visit the link below or copy into search engine:
http://www.cms.gov/medicare-coverag...SearchType=Exact&kq=true&bc=IAAAAAAAAAAAAA==&
MLN Matters®Number: SE1318
http://www.cms.gov/Outreach-and-Edu...k-MLN/MLNMattersArticles/Downloads/SE1318.pdf
"...... You must describe the histology of the specimens taken in the first stage. That description should include depth of invasion, pathological pattern, cell morphology, and, if present, perineural invasion or presence of scar tissue. For subsequent stages, you may note that the pattern and morphology of the tumor (if still seen) is as described for the first stage; or, if differences are found, note the changes. There is no need to repeat the detailed description documented for the first stage, presuming that the description would fit the tumor found on subsequent stages."
To access the revised LCDs, visit the link below or copy into search engine:
http://www.cms.gov/medicare-coverag...SearchType=Exact&kq=true&bc=IAAAAAAAAAAAAA==&